Found: 85
Select item for more details and to access through your institution.
Molecular genetic analysis of severe protein C deficiency.
- Published in:
- Human Genetics, 2000, v. 106, n. 6, p. 646, doi. 10.1007/s004390000315
- By:
- Publication type:
- Article
Patients Referred for Bleeding Symptoms of Unknown Cause: Does Evaluation of Thrombin Generation Contribute to Diagnosis?
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2016, v. 8, p. 1, doi. 10.4084/MJHID.2016.014
- By:
- Publication type:
- Article
Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children.
- Published in:
- Cardiology in the Young, 2009, v. 19, n. 2, p. 152, doi. 10.1017/S1047951109003503
- By:
- Publication type:
- Article
Von Willebrand disease - the ' Dos' and ' Don'ts' in surgery.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 2, p. 121, doi. 10.1111/ejh.12809
- By:
- Publication type:
- Article
The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.
- Published in:
- European Journal of Haematology, 2017, v. 98, p. 1, doi. 10.1111/ejh.12828
- By:
- Publication type:
- Article
Liposuction in Dercum's disease: impact on haemostatic factors associated with cardiovascular disease and insulin sensitivity.
- Published in:
- 1998
- By:
- Publication type:
- journal article
PP111 Toward Healthy Coagulation In Hemophilia.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Health‐related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study).
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 98, doi. 10.1111/hae.14899
- By:
- Publication type:
- Article
Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health‐related quality of life in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1032, doi. 10.1111/hae.14806
- By:
- Publication type:
- Article
No difference in quality of life between persons with severe haemophilia A and B.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 987, doi. 10.1111/hae.14759
- By:
- Publication type:
- Article
Clinical, economic, and health‐related quality of life burden associated with von Willebrand disease in adults and children: Systematic and targeted literature reviews.
- Published in:
- Haemophilia, 2023, v. 29, n. 2, p. 411, doi. 10.1111/hae.14655
- By:
- Publication type:
- Article
Area under the curve: Comparing the value of factor VIII replacement therapies in haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 145, doi. 10.1111/hae.14691
- By:
- Publication type:
- Article
Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 33, doi. 10.1111/hae.14676
- By:
- Publication type:
- Article
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A – A modified Delphi consensus by the ADVANCE Working Group.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 21, doi. 10.1111/hae.14674
- By:
- Publication type:
- Article
Sixth Åland Island Conference on von Willebrand disease.
- Published in:
- Haemophilia, 2022, v. 28, p. 3, doi. 10.1111/hae.14495
- By:
- Publication type:
- Article
Quality of life in a large multinational haemophilia B cohort (The B‐Natural study) – Unmet needs remain.
- Published in:
- Haemophilia, 2022, v. 28, n. 3, p. 453, doi. 10.1111/hae.14525
- By:
- Publication type:
- Article
Alternative payment models for durable and potentially curative therapies: The case of gene therapy for haemophilia A.
- Published in:
- Haemophilia, 2022, v. 28, p. 27, doi. 10.1111/hae.14425
- By:
- Publication type:
- Article
Clinical outcome and adherence rate in Scandinavian patients with intermediate‐intensity prophylaxis before and after the switch of standard half‐life FVIII products to BAY 81–8973.
- Published in:
- Haemophilia, 2022, v. 28, n. 2, p. 223, doi. 10.1111/hae.14489
- By:
- Publication type:
- Article
In response to WFH guidelines for the management of haemophilia, 3<sup>rd</sup> edition: Is there a difference between extended‐half‐life FVIII products or not?
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e762, doi. 10.1111/hae.14407
- By:
- Publication type:
- Article
The B‐Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 802, doi. 10.1111/hae.14357
- By:
- Publication type:
- Article
Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 793, doi. 10.1111/hae.14355
- By:
- Publication type:
- Article
Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B‐NORD study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 366, doi. 10.1111/hae.14299
- By:
- Publication type:
- Article
A comparison of MyPKFiT and WAPPS‐Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 417, doi. 10.1111/hae.14295
- By:
- Publication type:
- Article
Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study.
- Published in:
- Haemophilia, 2021, v. 27, n. 2, p. e253, doi. 10.1111/hae.14245
- By:
- Publication type:
- Article
Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B – The MoHem study.
- Published in:
- Haemophilia, 2020, v. 26, n. 5, p. 891, doi. 10.1111/hae.14114
- By:
- Publication type:
- Article
Achieving the unimaginable: Health equity in haemophilia.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 17, doi. 10.1111/hae.13862
- By:
- Publication type:
- Article
Joint comorbidities among Swedish carriers of haemophilia: A register‐based cohort study over 22 years.
- Published in:
- Haemophilia, 2019, v. 25, n. 5, p. 845, doi. 10.1111/hae.13831
- By:
- Publication type:
- Article
Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate‐ and high‐dose prophylaxis.
- Published in:
- Haemophilia, 2019, v. 25, n. 2, p. 244, doi. 10.1111/hae.13683
- By:
- Publication type:
- Article
Moderate haemophilia in focus.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Coagulation factor VIII is vital for increasing global coagulation after physical exercise.
- Published in:
- Haemophilia, 2019, v. 25, n. 2, p. e86, doi. 10.1111/hae.13652
- By:
- Publication type:
- Article
Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study.
- Published in:
- Haemophilia, 2019, v. 25, n. 2, p. 334, doi. 10.1111/hae.13640
- By:
- Publication type:
- Article
Cardiovascular disease‐related hospitalization and mortality among persons with von Willebrand disease: A nationwide register study in Sweden.
- Published in:
- Haemophilia, 2019, v. 25, n. 1, p. 109, doi. 10.1111/hae.13642
- By:
- Publication type:
- Article
Patient‐centred value framework for haemophilia.
- Published in:
- Haemophilia, 2018, v. 24, n. 6, p. 873, doi. 10.1111/hae.13456
- By:
- Publication type:
- Article
Models of prophylaxis.
- Published in:
- Haemophilia, 2012, v. 18, p. 136, doi. 10.1111/j.1365-2516.2012.02839.x
- By:
- Publication type:
- Article
Protecting the joints of mice and men.
- Published in:
- Haemophilia, 2008, v. 14, n. 1, p. 117, doi. 10.1111/j.1365-2516.2007.01626.x
- By:
- Publication type:
- Article
Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method.
- Published in:
- Biologics: Targets & Therapy, 2014, v. 8, p. 115, doi. 10.2147/BTT.S53456
- By:
- Publication type:
- Article
Properties of Factor IX Concentrates.
- Published in:
- Acta Haematologica, 1995, v. 94, n. S1, p. 8, doi. 10.1159/000204021
- By:
- Publication type:
- Article
Therapeutic choices for patients with hemophilia and high-titer inhibitors.
- Published in:
- American Journal of Hematology, 2002, v. 69, n. 2, p. 155, doi. 10.1002/ajh.1192
- By:
- Publication type:
- Article
Therapeutic choices for patients with hemophilia and high-titer inhibitors.
- Published in:
- American Journal of Hematology, 2001, v. 67, n. 4, p. 240, doi. 10.1002/ajh.1123
- By:
- Publication type:
- Article
Modeling Costs and Outcomes Associated with a Treatment Algorithm for Problem Bleeding Episodes in Patients with Severe Hemophilia A and High-Titer Inhibitors.
- Published in:
- American Health & Drug Benefits, 2011, v. 4, n. 4, p. 219
- By:
- Publication type:
- Article
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human α<sub>1</sub>-antitrypsin.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 2, p. 151, doi. 10.1007/s00228-003-0589-z
- By:
- Publication type:
- Article
Book reviews.
- Published in:
- 2003
- By:
- Publication type:
- Book Review
HIV-serology and lymphocyte subsets in relation to therapy and clinical development in haemophiliacs.
- Published in:
- European Journal of Haematology, 1988, v. 41, n. 5, p. 459, doi. 10.1111/j.1600-0609.1988.tb00228.x
- By:
- Publication type:
- Article
Biochemical and in vivo properties of commercial virus-inactivated factor VIII concentrates.
- Published in:
- European Journal of Haematology, 1988, v. 40, n. 3, p. 205, doi. 10.1111/j.1600-0609.1988.tb00825.x
- By:
- Publication type:
- Article
(<sup>3</sup>H)ouabain binding to leukaemic cells and intralymphocytic sodium content in chronic lymphocytic leukaemia; no evidence for alterations of the Na<sup>+</sup>/K<sup>+</sup>-pump.
- Published in:
- European Journal of Haematology, 1987, v. 38, n. 1, p. 31, doi. 10.1111/j.1600-0609.1987.tb01420.x
- By:
- Publication type:
- Article
Psychosocial Self-Prognosis in Relation to Mortality and Morbidity in Hemophiliacs with HIV Infection.
- Published in:
- Psychotherapy & Psychosomatics, 1994, v. 62, n. 3/4, p. 185, doi. 10.1159/000288921
- By:
- Publication type:
- Article
Coping Style in Relation to the Consumption of Factor Concentrate in HIV-Infected Hemophiliacs during the Years after Their Infection Became Known.
- Published in:
- Psychotherapy & Psychosomatics, 1994, v. 61, n. 3/4, p. 205, doi. 10.1159/000288891
- By:
- Publication type:
- Article
Combination of FVIII and by-passing agent potentiates in vitro thrombin production in haemophilia A inhibitor plasma J. Klintman et al Potentiating Thrombin Production In Vitro in Haemophilia A.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 4, p. 381, doi. 10.1111/j.1365-2141.2010.08378.x
- By:
- Publication type:
- Article
Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 2, p. 342, doi. 10.1046/j.1365-2141.2002.03853.x
- By:
- Publication type:
- Article
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 1, p. 87, doi. 10.1046/j.1365-2141.2001.02700.x
- By:
- Publication type:
- Article